Epirubicin and Thalidomide in Treating Patients With Liver Cancer

NCT00058487 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

DRUG: epirubicin hydrochloride
DRUG: thalidomide

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]